Development of ritonavir-loaded nanostructured lipid carriers employing quality by design (QbD) as a tool: characterizations, permeability, and bioavailability studies-Reference-Cited by-同舟云学术

Development of ritonavir-loaded nanostructured lipid carriers employing quality by design (QbD) as a tool: characterizations, permeability, and bioavailability studies

Published:2021-10-20 Issue: Volume: Page:
ISSN:2190-393X
Container-title:Drug Delivery and Translational Research
language:en
Short-container-title:Drug Deliv. and Transl. Res.

Author:

Gurumukhi Vishal C.^ORCID,Bari Sanjaykumar B.

Publisher

Springer Science and Business Media LLC

Subject

Pharmaceutical Science

Link

https://link.springer.com/content/pdf/10.1007/s13346-021-01083-5.pdf

Reference63 articles.

1. Kaspera R, Kirby BJ, Sahele T, Collier AC, Kharasch ED, Unadkat JD, et al. Investigating the contribution of CYP2J2 to ritonavir metabolism in vitro and in vivo. Biochem Pharmacol. 2014;91:109–18.

2. Patel D, Patel B, Patel C. Spectrophotometric method for simultaneous estimation of atazanavir sulfate and ritonavir in tablet dosage form. Drug Dev Ther. 2015;6:1.

3. Sudhakar B, Krishna MC, Murthy KVR. Factorial design studies of antiretroviral drug-loaded stealth liposomal injectable: PEGylation, lyophilization and pharmacokinetic studies. Appl Nanosci [Internet]. Springer Berlin Heidelberg; 2016;6:43–60. Available from: https://doi.org/10.1007/s13204-015-0408-8

4. Ahammed V, Narayan R, Paul J, Nayak Y, Roy B, Shavi G V, et al. Development and in vivo evaluation of functionalized ritonavir proliposomes for lymphatic targeting. Life Sci [Internet]. Elsevier Inc.; 2017;183:11–20. Available from: https://doi.org/10.1016/j.lfs.2017.06.022

5. Makwana V, Jain R, Patel K, Nivsarkar M, Joshi A. Solid lipid nanoparticles (SLN) of Efavirenz as lymph targeting drug delivery system: Elucidation of mechanism of uptake using chylomicron flow blocking approach. Int J Pharm [Internet]. Elsevier BV; 2015;495:439–46. Available from: https://doi.org/10.1016/j.ijpharm.2015.09.014

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Facilitating the use of the target product profile in academic research: a systematic review;Journal of Translational Medicine;2024-07-29

2. Design of Optimized Solid Lipid Nanoparticles of Montelukast Sodium and Assessment of Oral Bioavailability in Experimental Model;Current Pharmaceutical Biotechnology;2024-06-24

3. D-Optimal Mixture Design Enabled Development of Lyophilized Nanoemulsifying Drug Delivery System of Paliperidone;Drug Delivery Letters;2024-06

4. Development and characterization of solid lipid-based formulations (sLBFs) of ritonavir utilizing a lipolysis and permeation assay;European Journal of Pharmaceutical Sciences;2024-05

5. Nanostructured Lipid Carriers for Improved Delivery of Therapeutics via the Oral Route;Journal of Nanotechnology;2023-11-06